Tag: cell therapy

ViGenCell’s VT-EBV-N has begun South Korea’s first approved advanced regenerative medicine treatment, giving patients with high-risk EBV-positive lymphoma access to a personalized T-cell therapy while generating real-world clinical and manufacturing data.

Clinical research on cell therapy for high-risk diffuse large B-cell lymphoma begins, despite the risk of relapse in complete remission.

JNPMEDI will support clinical trials for speroQure, a novel cell therapy for osteoarthritis, ensuring a smooth and effective process.

Matica Bio launches an open CDMO platform for gene therapy, enhancing client control and streamlining production with Cirsium Biosciences.

GC Cell receives final certification from Japan for cell processing products, validating its manufacturing and quality systems for regenerative medicine.

Matica BioLabs partners with UC Therapeutics to manufacture CAR-NK cell therapy, enhancing cancer treatment through dual-targeting technology.

HLB Innovation appoints Dr. Dennis Williams as VP of Regulatory Affairs at Verismo Therapeutics to enhance global regulatory strategies.

GC Cell has completed the registration of core technology patents for next-gen cell and gene therapies in South Korea and Japan.

CHA Bio Group partners with CIC to create a global bio-ecosystem, enhancing support for biotech firms in cell and gene therapy.